Skip to main content
. 2019 May 7;24(11):e1197–e1211. doi: 10.1634/theoncologist.2018-0876

Table 2. Baseline characteristics for phase III trials.

image

Abbreviations: CNS, central nervous system; ECOG PS, Eastern Cooperative Oncology Group performance status; ICC, investigator choice chemotherapy; LDH, lactate dehydrogenase; NR, not reported; q2w, every 2 weeks; q3w, every 3 weeks; ULN, upper limit of normal.